Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer is a research paper published in Endocrinology (2023). On theSindex it has a DataRank of 0.460. It has been cited 10 times, with 6 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.360
From this paper's citation signal
Citation Network Contribution
0.101
From 4 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 6 citers.
Breast Cancer Research Program
Grant: W81XWH-20-1-0759
Breast Cancer Research Program
Grant: W81XWH-20-1-0760
Tumor Biology Training
Grant: T32 CA009686
NCI Cancer Center Support
Grant: P30 CA051008
FWCI
1.67
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals